# A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

> **NCT01862224** · PHASE2 · TERMINATED · sponsor: **Janssen Research & Development, LLC** · enrollment: 21 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** JNJ-38518168
- **DRUG:** Placebo
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT01862224
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** The study was stopped due to lack of efficacy in a study conducted in a similar population,38518168ARA2002-NCT01679951.
- **Last updated:** 2015-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01862224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01862224, "A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01862224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*